Related Experiment Video
Updated: Dec 5, 2025
10:26
In Vitro Differentiation Model of Human Normal Memory B Cells to Long-lived Plasma Cells
Published on: January 20, 2019
12.8K
The m6A Methyltransferase METTL3 Is Functionally Implicated in DLBCL Development by Regulating m6A Modification in
Yingying Cheng1, Yuanyuan Fu2, Ying Wang2
1Department of Hematology, The First Affiliated Hospital, College of Clinical Medicine of Henan University of Science and Technology, Luoyang, China.
Frontiers in Genetics
|October 16, 2020
Summary
METTL3, a key RNA methylation enzyme, promotes Diffuse Large B-cell Lymphoma (DLBCL) progression. Inhibiting METTL3 reduces DLBCL cell proliferation by decreasing pigment epithelium-derived factor (PEDF) levels.
Area of Science:
- Oncology
- Molecular Biology
- Epigenetics
Background:
- Diffuse Large B-cell Lymphoma (DLBCL) is the most common lymphoma subtype with challenging curative effects.
- The underlying pathogenic mechanisms of DLBCL remain incompletely understood.
- N6-methyladenosine (m6A) mRNA methylation is implicated in cancer pathogenesis, but its role in DLBCL is unclear.
Purpose of the Study:
- To investigate the role of METTL3 in the development and progression of DLBCL.
- To explore the functional link between m6A mRNA methylation and DLBCL pathogenesis.
Main Methods:
- Analysis of m6A levels and METTL3 expression in DLBCL tissues and cell lines.
- Functional assays to assess the impact of METTL3 knockdown on DLBCL cell proliferation.
- Mechanism analysis involving m6A methylation, PEDF mRNA levels, and Wnt/β-catenin signaling.
Main Results:
- METTL3 expression and m6A levels were elevated in DLBCL tissues and cell lines.
- Downregulation of METTL3 inhibited DLBCL cell proliferation.
- METTL3 knockdown reduced m6A methylation and total mRNA levels of pigment epithelium-derived factor (PEDF).
- Overexpression of PEDF rescued the inhibitory effect of METTL3 silence on DLBCL cell proliferation.
Conclusions:
- METTL3 promotes DLBCL progression.
- METTL3 regulates DLBCL progression by controlling the m6A methylation level of PEDF.
- Targeting METTL3 may offer a potential therapeutic strategy for DLBCL.
More Related Videos
Related Concept Videos
02:23Abnormal Proliferation
5.0K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
02:23Master Transcription Regulators
7.5K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.5K